Egetis Therapeutics AB (LTS:0ABW) Total Long-Term Assets : kr418.00 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Egetis Therapeutics AB Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Egetis Therapeutics AB's Total Long-Term Assets for the quarter that ended in Mar. 2025 was kr418.00 Mil.

Egetis Therapeutics AB Total Long-Term Assets Historical Data

The historical data trend for Egetis Therapeutics AB's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Total Long-Term Assets Chart

Egetis Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Assets

Get a 7-Day Free Trial

417.13

416.40

413.70

414.30

412.20

Egetis Therapeutics AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Assets	Get a 7-Day Free Trial															414.20	414.10	413.10	412.20	418.00

Egetis Therapeutics AB Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Egetis Therapeutics AB Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Egetis Therapeutics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (LTS:0ABW) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

EGTX:Sweden P0F:Germany

Address

Grev Turegatan 11 C, Stockholm, SWE, 114 46

Website

https://www.egetis.com

Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines